News Archives - JCR Pharmaceuticals

JCR organizes and conducts API plant tour for local residents

by Moises Zanetti

Shin Ashida of JCR Pharmaceuticals named Kansai Regional Representative in EY Entrepreneur of The Year(TM) 2025 Japan

by Chris Miller

JCR Pharmaceuticals enhances delivery of AAV gene therapy to central nervous system and muscle with novel capsid engineering platform technology

by Moises Zanetti

JCR Pharmaceuticals announces licensing agreement with Menagen to commercialize Agalsidase Beta BS I.V. Infusion [JCR] across nine MENAT markets

by Moises Zanetti

JCR Pharmaceuticals to present at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress

by Moises Zanetti

Notice of orphan drug designation for JR-446 for mucopolysaccharidosis type IIIB by Ministry of Health, Labour and Welfare of Japan

by Moises Zanetti

JCR Pharmaceuticals unveils new corporate tagline, “Life is Rare,” to mark its 50th anniversary

by Moises Zanetti

Notice of personnel change

by Moises Zanetti

JCR Pharmaceuticals and Alexion achieve milestone in collaborative neurodegenerative disease program

Notice of personnel change